Paving the Way for Stem Cell Therapies

Scale Your Cell Culture Up to 100 Billion Cells per Batch
Discover How

Accelerating the Future of Cell & Gene Therapy

At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization. Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.

See What Powers Us >

We Offer

Featured Products

Events & News

More Events&News >

MSC Culture Media Selection in the Era of Regulatory Convergence: From Risk Control to Submission Readiness

Feb 12,2026

MSC Culture Media Selection in the Era of Regulatory Convergence: From Risk Control to Submission Readiness

A regulatory-focused analysis of MSC culture media, highlighting risk control, viral safety, and submission-ready strategies for scalable manufacturing.
CITCI – Cumbre Internacional de Terapias Celulares e Inmunológicas

Feb 12,2026

CITCI – Cumbre Internacional de Terapias Celulares e Inmunológicas

May 6–9, 2026 | Convention Centre Dublin, Ireland
Breaking the 2D Ceiling: Why 3D Microcarriers are the Future of Biomanufacturing

Jan 30,2026

Breaking the 2D Ceiling: Why 3D Microcarriers are the Future of Biomanufacturing

Move beyond 2D limits. 3D microcarriers replace harsh 2D trypsinisation with gentle dissolution, ensuring superior cell viability and biological potency.

We are always looking forward to hear from you.

Security verification
Submit Your Request